Does Retatrutide (GLP-3) Cause Hair Loss?

Direct Answer

Hair shedding reported by some people using retatrutide is generally understood to be telogen effluvium, a temporary, stress-related hair loss pattern triggered by rapid weight loss and significant caloric restriction itself, not a direct pharmacological effect of the medication. This same pattern is well-documented across GLP-1 medications broadly, covered in more detail on our Hair Loss symptom page, and retatrutide's substantial average weight loss may make this particular side effect more noticeable simply because the underlying trigger, rapid weight change, is often more pronounced.

Why Faster, Larger Weight Loss May Mean More Noticeable Shedding

Telogen effluvium is triggered by significant physiological stress on the body, and larger, faster weight changes represent a bigger stress signal than slower, more gradual loss. Since retatrutide has produced some of the largest average weight loss percentages seen in this medication class, around 24% or more at higher doses, the underlying trigger for this temporary shedding pattern may simply be more common or pronounced than with medications producing smaller average results.

The Reassuring Part

This pattern is well-understood, temporary, and not typically a sign of permanent hair loss or a reason to stop treatment on its own. It typically appears 2 to 4 months into significant weight loss and resolves as the body adjusts.

What Actually Helps

Adequate protein intake and overall nutritional adequacy during rapid weight loss are the most consistently supported ways to help minimize this effect, the same practical guidance covered on our existing Hair Loss and Protein pages.

References

• PeptideDeck: Retatrutide, Bodybuilding, Nausea, Muscle Loss, Hair Loss & Plateau (2026)

Related Resources

• Hair Loss
• Protein

Explore More

Explore the full GLP-1 Tracker knowledge base on DietApp.com

Get Started

Track retatrutide alongside every other GLP-1 medication on DietApp.com.

About DietApp.com

DietApp.com combines evidence-based GLP-1 medication education with practical treatment tracking tools. Retatrutide is investigational and not FDA-approved. This article is for general informational purposes and is not medical advice.